Physician profile
David A Simonson
NPI 1770561805
$8,714.71
in general payments reported to CMS, 2019-2025
39 companies · $1,549 in 2025
The $1,549 reported for 2025 was more than what 87% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,387 · 2020: $876 · 2021: $255 · 2022: $862 · 2023: $1,077 · 2024: $709 · 2025: $1,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,847 · Travel and Lodging: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,847.00 |
| Travel and Lodging | $488.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $2,115.21 | 2019 | |
| Arthrex, INC. | $1,234.59 | 2023-2025 | Distal Extremities Implants Foot & Ankle Cfs |
| Paratek Pharmaceuticals, INC. | $945.71 | 2022-2025 | Nuzyra |
| Smith+Nephew, INC. | $889.24 | 2019-2025 | Renasys Touch, Oasis |
| Wright Medical Technology, INC. | $777.71 | 2020 | |
| Next Science LLC | $416.04 | 2022-2024 | Blastx, Xperience, Surgx |
| Stryker Corporation | $397.66 | 2019-2025 | Easyfuse |
| Biocomposites INC | $160.85 | 2023 | Stimulan |
| Boston Scientific Corporation | $146.21 | 2025 | Ranger |
| Kowa Pharmaceuticals America, INC. | $144.27 | 2022-2023 | Seglentis |
| Amgen INC. | $142.30 | 2024-2025 | Krystexxa |
| Merck Sharp & Dohme LLC | $140.53 | 2019 | |
| Integra Lifesciences Corporation | $125.02 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $120.54 | 2019-2022 | |
| Horizon Therapeutics Plc | $112.52 | 2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $86.60 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $75.97 | 2024-2025 | |
| Kci USA, INC. | $75.91 | 2019-2023 | V.A.C. Dermatac |
| Tactile Systems Technology INC | $53.59 | 2021-2025 | |
| Abbvie INC. | $49.48 | 2022 | |
| Depuy Synthes Sales INC. | $47.08 | 2023 | N/A |
| Kerecis Limited | $35.32 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Reel Surgical, INC. | $34.42 | 2024 | |
| Convatec INC. | $33.48 | 2023-2024 | |
| Solventum Corporation | $33.21 | 2024-2025 | Activ.A.C., 3m Cavilon |
| Medtronic, INC. | $32.94 | 2021 | |
| Orthofix Medical, INC. | $32.77 | 2022 | |
| Nabriva Therapeutics, Plc | $31.54 | 2021-2022 | |
| Reprise Biomedical, INC. | $31.01 | 2024 | Miro3d |
| Embody, INC. | $29.87 | 2021-2022 | |
| Averitas Pharma INC. | $26.17 | 2024 | Qutenza |
| Sanara Medtech INC. | $24.30 | 2023 | Celleraterx |
| Axogen | $19.42 | 2021 | |
| Misonix INC | $18.18 | 2019 | |
| Ermi LLC | $17.56 | 2020 | |
| Abbott Laboratories | $16.04 | 2024 | Eterna |
| Cashflow Solutions, LLC | $14.46 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Hartmann USA, INC. | $13.61 | 2025 | Zetuvit Plus 10x10 P10 |
| Urgo Medical North America, LLC | $13.38 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Simonson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.